Ge Healthcare Technologies Inc (GEHC) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ge Healthcare Technologies Inc   (NASDAQ: GEHC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Ge Healthcare Technologies Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ge Healthcare Technologies Inc's ROI in the third quarter of 2026?
Ge Healthcare Technologies Inc achieved a return on average invested assets (ROI) of 7.65 % in its third quarter of 2026, this is above GEHC's average return on investment of 7.6%.
Ge Healthcare Technologies Inc s investments during the 12 months ending in the third quarter of 2026 are valued at $28 billion

ROI has improved compared to 7.26% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 62 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1161, from total ROI ranking in the second quarter of 2026 at 1205.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 9.47 % 9.87 % 11.65 % 13.81 % 9.54 %
Y / Y Net Income Change TTM -4.37 % -11.97 % 8.93 % 75.55 % 367.14 %
Investment (TTM) in Millions 29,557 28,943 28,340 27,608 27,436
Return On Investment (TTM) 7.65 % 7.26 % 7.17 % 7.93 % 8.76 %
GEHC's Overall Ranking # 1161 # 1205 # 881 # 844 # 847
Seq. Investment Change TTM 1.89 % 1.81 % 1.53 % 3.95 % 2.26 %
Seq. Net Income Change TTM 7.41 % 3.09 % -8.22 % -5.9 % -1.12 %
Net Income (TTM) in Millions 2,189 2,038 1,977 2,154 2,289

GEHC Company Profile >> Back to GEHC Roi Comparisons >> See Annual GEHC Return On Investment



Return On Investment GEHC's Ranking
Within: No.
Industry # 4
Sector # 63
Overall # 1161

Return On Investment Statistics
High Average Low
9.08 %
7.6 %
6.28 %
(Mar 31 2025)   (Mar 31 2023)







Financial Statements
Ge Healthcare Technologies Inc's III. Quarter Investments $ 29,557 Millions GEHC's Balance sheet
Ge Healthcare Technologies Inc's III. Quarter Income $ 615 Millions Quarterly GEHC's Income Statement
GEHC's Income by Division See GEHC's Income by Division


GEHC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023

Total Investments in Millions 27,608 23,480 23,405 0 0
Y / Y Investment Growth 17.58 % 0.32 % - - -
Net Income in Millions 2,154 2,050 1,614 0 0
Y / Y Net Income Growth 5.07 % 27.01 % - - -
Annual Return On Investment 7.8 % 8.73 % 6.9 % - -


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 7.8 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GEHC's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GEHC's Competitors
Subscribers only: Roi for Ge Healthcare Technologies Inc's Suppliers
Subscribers only: Return On Investment for GEHC's Customers

Other Ratios
GEHC's Roa GEHC's Inventory Turnover Ratio GEHC's Growth Rates GEHC's Dividend Statistics
GEHC's Profitability Ratios GEHC's Asset Turnover Ratio GEHC's Dividend Growth
GEHC's Roe GEHC's Valuation Ratios GEHC's Financial Strength Ratios GEHC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %

Date modified: 2026-10-29T17:23:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.